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I n t R o d u c t I o n
The function of arteries and arterioles is to deliver the 
blood pumped by the heart to organs. Smooth muscle 
cells lining the walls of these vessels have an intrinsic 
ability to contract in response to increases in intravas-
cular pressure (Bayliss, 1902). This behavior, termed 
the myogenic response, is initiated by stretch-induced 
activation of nonselective cation channels of the tran-
sient receptor potential family, including TRPP2, 
TRPC6, and TRPM4, which depolarize arterial myo-
cytes (Welsh et al., 2002; Earley et al., 2004; Spassova 
et al., 2006; Narayanan et al., 2013; Gonzales et al., 
2014). Membrane depolarization, in turn, activates volt-
age-gated L-type CaV1.2 channels (Harder et al., 1987; 
Fleischmann et al., 1994; Rubart et al., 1996; Jaggar et 
al., 1998; Knot and Nelson, 1998). The resulting influx 
of Ca2+ via a single CaV1.2 channel produces a local el-
evation in intracellular Ca2+ that can be detected opti-
cally in the form of a “CaV1.2 sparklet” (Navedo et al., 
2005, 2007; Amberg et al., 2007). Activation of multiple 
CaV1.2 sparklets induces a global increase in intracel-
lular Ca2+ concentration ([Ca2+]i) that activates myosin 
light chain kinase, thus initiating contraction. This myo-
genic response is critical for the process of autoregula-
tion of blood flow by resistance vessels.
As is the case with other important physiological pro-
cesses, the myogenic response varies between females 
and males. For example, cerebral, coronary, and co-
chlear arteries from male rodents have a higher level 
of myogenic tone than the same arteries from females 
(Wellman et al., 1996; Geary et al., 2000a,b). Although 
multiple studies have demonstrated that the endothe-
lium is a major contributor to sex-specific differences 
in arterial and arteriolar function (Wellman et al., 
1996; Lamping and Faraci, 2001; Sader and Celermajer, 
2002; Villar et al., 2008; Chrissobolis and Faraci, 2010), 
whether smooth muscle contributes to these differ-
ences is unclear.
Several studies have suggested higher expression 
of PKC in male than female aortic smooth muscle 
(Kanashiro and Khalil, 2001; Maddali et al., 2005). One 
protein that is expressed in vascular smooth muscle cells 
and is subject to regulation by PKCα is the TRPV4 (tran-
sient receptor potential vanilloid 4) channel. Like CaV1.2 
channels, TRPV4 channels are permeable to Ca2+ and 
produce analogous local Ca2+-signaling events termed 
“TRPV4 sparklets” (Liedtke et al., 2000; Strotmann et al., 
2000; Sonkusare et al., 2012; Mercado et al., 2014). TRPV4 
sparklets reflect a degree of Ca2+ entry that exceeds that 
of CaV1.2 sparklets by ∼100-fold (Mercado et al., 2014). 
However, because basal TRPV4 sparklet activity in ar-
terial myocytes is very low, these events do not increase 
global [Ca2+]i and thus do not contribute to contraction. 
TRPV4 (transient receptor potential vanilloid 4) channels are Ca2+-permeable channels that play a key role in 
regulating vascular tone. In arterial myocytes, opening of TRPV4 channels creates local increases in Ca2+ influx, 
detectable optically as “TRPV4 sparklets.” TRPV4 sparklet activity can be enhanced by the action of the vasocon-
strictor angiotensin II (AngII). This modulation depends on the activation of subcellular signaling domains that 
comprise protein kinase C α (PKCα) bound to the anchoring protein AKAP150. Here, we used super-resolution 
nanoscopy, patch-clamp electrophysiology, Ca2+ imaging, and mathematical modeling approaches to test the 
hypothesis that AKAP150-dependent modulation of TRPV4 channels is critically dependent on the distance be-
tween these two proteins in the sarcolemma of arterial myocytes. Our data show that the distance between 
AKAP150 and TRPV4 channel clusters varies with sex and arterial bed. Consistent with our hypothesis, we further 
find that basal and AngII-induced TRPV4 channel activity decays exponentially as the distance between TRPV4 
and AKAP150 increases. Our data suggest a maximum radius of action of ∼200 nm for local modulation of TRPV4 
channels by AKAP150-associated PKCα.
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Instead, TRPV4 channels in these cells have been linked 
to relaxation through a mechanism in which activation 
of TRPV4 channels by the endothelium-derived factor 
11,12-epoxyeicosatrienoic acid (11,12-EET) results in an 
influx of Ca2+ that activates nearby ryanodine receptors 
(Earley et al., 2005, 2009). These receptors then release 
Ca2+ from the SR in the form of a local Ca2+ spark, which 
activates juxtaposed large-conductance, Ca2+-activated K+ 
(BK) channels in the plasma membrane (Nelson et al., 
1995). This results in membrane hyperpolarization and 
closure of CaV1.2 channels, thereby decreasing [Ca2+]i 
and causing myocyte relaxation.
TRPV4 channels are activated by exposure of smooth 
muscle cells to the vasoconstrictor angiotensin II (AngII; 
Mercado et al., 2014), which acts through activation 
of heteromeric Gq proteins to increase diacylglycerol 
(DAG) levels, leading to stimulation of PKCα activity. 
PKCα is targeted to the sarcolemma of vascular smooth 
muscle cells by the scaffolding protein AKAP150. In-
deed, both AKAP150 and PKCα are necessary for acute 
and chronic AngII-induced changes in Ca2+ signaling 
and myogenic tone (Navedo et al., 2008; Nieves-Cin-
trón et al., 2008; Nystoriak et al., 2014). Although the 
concept that TRPV4 channels are locally controlled by 
AKAP150-associated proteins has been demonstrated in 
several cell types, including endothelial cells and vas-
cular smooth muscle cells (Fan et al., 2009; Mercado 
et al., 2014; Sonkusare et al., 2014), a fundamental, yet 
unanswered, question is how close must these proteins 
be to one another for effective signaling.
In this study, we sought to provide a quantitative an-
swer to this difficult question by investigating the spatial 
and functional organization of TRPV4 channels in vas-
cular smooth muscle cells using a combination of total 
internal reflection fluorescence (TIRF) imaging and 
super-resolution nanoscopy. Applying a multipronged 
approach, we determined TRPV4 channel activity in 
myocytes from mesenteric arteries, pial arteries, and 
parenchymal arterioles (hereafter referred to as mes-
enteric, pial, and parenchymal myocytes, for simplicity) 
isolated from female and male mice. We also deter-
mined the distance between AKAP150 and TRPV4 clus-
ters in these cells using super-resolution microscopy. 
Our data suggest that basal and AngII-induced TRPV4 
sparklet activity varies depending on the vessel from 
which the cells were obtained as well as the sex of the 
animal. Indeed, overall TRPV4 sparklet activity was 
lower in pial and parenchymal myocytes from female 
than male mice and surprisingly was undetectable in 
mesenteric myocytes from animals of either sex. An 
analysis of super-resolution images and TRPV4 sparklet 
data suggests that TRPV4 channel activity decays expo-
nentially as the distance between TRPV4 and AKAP150 
increases. Indeed, our data indicate a critical cutoff of 
∼200 nm for local modulation of TRPV4 channels by 
AKAP150-associated PKCα.
M At e R I A l s  A n d  M e t h o d s
Isolation of myocytes from pial and mesenteric arteries 
and parenchymal arterioles
Male and female WT C57BL/6J (The Jackson Labora-
tory) and AKAP150 null (AKAP150−/−) mice were used 
in this study. Animals were euthanized by decapitation 
after intraperitoneal administration of a lethal dose of 
sodium pentobarbital (250 mg/kg). All experiments 
were conducted in accordance with the University of 
California Institutional Animal Care and Use Commit-
tee guidelines. Myocytes for TIRF and super-resolution 
microscopy were dissociated from pial cerebral arteries, 
parenchymal cerebral arterioles, and mesenteric ar-
teries using previously described approaches (Navedo 
et al., 2005; Tajada et al., 2013; Li et al., 2014; Mer-
cado et al., 2014).
In brief, for pial (basilar, posterior, and mid-cere-
bral) arteries, the brain was rapidly removed from 
the skull and placed in cold Mg2+–physiological salt 
solution (Mg2+-PSS; 140  mM NaCl, 5  mM KCl, 2  mM 
MgCl2, 10 mM HEP ES, and 10 mM glucose), adjusted 
to pH 7.4 with NaOH. Pial arteries were dissected out, 
cleaned of connective tissue, and incubated for 8 min 
at 37°C in Mg+2-PSS supplemented with 0.3 mg/ml pa-
pain (Worthington Biochemical Corporation) and 0.3 
mg/ml dithiothreitol (DTT; Sigma-Aldrich), followed 
by a second incubation (5 min at 37°C) in Mg2+-PSS 
supplemented with 0.3 mg/ml type F and 0.7 mg/
ml type H collagenase (Sigma-Aldrich). Arteries were 
then washed with Mg2+-PSS and kept on ice in the same 
solution for 30 min, after which cells were gently tritu-
rated with a fire-polished Pasteur pipette to yield a sin-
gle-cell suspension.
Parenchymal arterioles were cut near their junc-
tion to the mid-cerebral artery. The arachnoid mater 
around the middle cerebral artery was gently removed 
from the brain such that parenchymal arterioles re-
mained attached to the middle cerebral artery. Arte-
rioles were dissected in cold MOPS-buffered saline 
solution (145  mM NaCl, 5  mM KCl, 1  mM MgSO4, 
2.5 mM CaCl2, 1 mM KH2PO4, 3 mM MOPS, 2 mM py-
ruvate, 5 mM glucose, and 1% BSA, pH 7.4). Arteriole 
segments were then placed in a glutamate isolation 
solution (55  mM NaCl, 5.6  mM KCl, 80  mM Na-glu-
tamate, 2 mM MgCl2, 10 mM HEP ES, and 10 mM glu-
cose), adjusted to pH 7.3 with NaOH, and incubated 
first in 0.5 mg/ml papain and 1.0 mg/ml dithioeryth-
ritol (DTE; Sigma-Aldrich) for 11 min at 37°C, and 
then in 1.0 mg/ml collagenase type F for 13 min at 
37°C. The digested segments were washed three times 
in ice-cold glutamate isolation solution and incubated 
on ice in the same solution for 30 min. Digested arteri-
oles were gently triturated to dissociate smooth muscle 
cells and stored in ice-cold glutamate isolation solu-
tion until used.
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Third-order mesenteric arteries were dissected out, 
placed in an ice-cold smooth muscle dissociation solu-
tion (145  mM NaCl, 4.2  mM KCl, 0.6  mM KH2PO4, 
1.2 mM MgCl2, 10 mM HEP ES, and 11 mM glucose), 
adjusted to pH 7.4 with NaOH, and carefully cleaned 
of adipose and connective. Arteries were cut into small 
segments and then placed in dissociation solution sup-
plemented with 0.5 mg/ml papain, 1 mg/ml BSA (Sig-
ma-Aldrich), and 1 mg/ml DTE, and incubated for 9–15 
min at 37°C. This was followed by a second 12- to 16-
min incubation in dissociation solution containing 10 
μM Ca2+, 0.6 mg/ml collagenase F, and 1 mg/ml BSA. 
After rinsing the arteries twice with dissociation solu-
tion containing 10 μM Ca2+, single cells were obtained 
by gentle trituration with a wide-bore glass pipette. Cells 
were maintained at 4°C until used.
Electrophysiology and [Ca2+]i imaging
After isolation, cells were kept in ice-cold Mg2+-PSS solu-
tion for about an hour before TRPV4 currents were 
recorded. Electrophysiological measurements were re-
corded at room temperature using the conventional or 
amphotericin B–perforated patch whole-cell configura-
tion of the patch-clamp technique as described before 
(Amberg et al., 2003; Mercado et al., 2014). Freshly 
isolated myocytes were placed directly in the recording 
chamber and allowed to settle for a few minutes before 
starting perfusion with the external solution (com-
posed of 134 mM NaCl, 6 mM KCl, 1 mM MgCl2, 2 mM 
CaCl2, 10 mM glucose, and 10 mM HEP ES). Patch pi-
pettes were made from borosilicate glass (2.0 mm O.D.; 
World Precision) using a P-97 automatic puller (Sutter 
Instrument); resistances ranged from 4 to 8 MΩ when 
filled with the internal solution (composed of 110 mM 
K-aspartate, 30  mM KCl, 10  mM NaCl, 1  mM MgCl2, 
and 10  mM HEP ES). For experiments involving the 
recording of [Ca2+]i and ITRPV4 in mesenteric myocytes 
(see Fig.  8), active PKCα (0.1 U/ml; Millipore) was 
added to the internal solution. The kinase was activated 
by the inclusion of the DAG analogue 1-oleoyl-2-acetyl-
sn-glycerol (OAG; 10 µM) and 90 nM free Ca2+ in the 
pipette solution. TRPV4 currents were recorded using 
an Axopatch 200B patch-clamp amplifier, filtered at 2 
kHz (−3 dB, four-pole Bessel filter) and sampled at 10 
kHz. Current recordings were digitized with a Digidata 
1440A interface using CLA MPEX 10 software (Mo-
lecular Devices).
TRPV4 sparklets were recorded in voltage-clamped 
(membrane potential = −70 mV) arterial myocytes using 
a through-lens TIRF system built around an inverted 
Olympus IX-70 microscope equipped with an Olym-
pus PlanApo (60×; NA = 1.49) oil-immersion lens and 
an Andor iXON EMC CD camera (pixel size = 13 µm). 
Cells were continuously superfused with a solution with 
the following composition: 142 mM NaCl, 6 mM KCl, 
1 mM MgCl2, 2 mM CaCl2, 10 mM glucose, and 10 mM 
HEP ES, adjusted to pH 7.4. Nifedipine (10 µM; EMD 
Millipore) was added to eliminate Ca2+ influx through 
L-type calcium channels and thapsigargin (1  µM) to 
eliminate Ca2+ release from the SR. To monitor [Ca2+]i, 
cells were patch-clamped in the whole-cell configuration 
using pipettes filled with a solution composed of 100 mM 
Na-glutamate, 20  mM NaCl, 42  mM mannitol, 1  mM 
MgCl2, 4 mM Na2-ATP, 10 mM EGTA, 10 mM HEP ES, 
and 0.2  mM Rhod-2 (Invitrogen), adjusted to pH 7.2 
with NaOH. Rhod-2 was excited with a 563-nm laser. 
Excitation and emission light were separated using the 
appropriate set of filters.
TIRF images were acquired at a frequency of 100–300 
Hz using TILL Image software. Sparklets were detected 
and analyzed using custom software written in MAT LAB 
(Navedo et al., 2010; Mercado et al., 2014). Fluores-
cence intensity values were converted to nanomolar 
units as described previously (Navedo et al., 2005, 
2006). Histograms from all [Ca2+]i records obtained 
from arterial myocytes were fit to the following multi-
component Gaussian function:
  N =  ∑ j=1 n  a j * exp [−     (Δ [ Ca 2+ ] i − jq) 
2
 
  ____________2jb ] , 
where a and b are constants, and Δ[Ca2+]i and q are 
the change in intracellular Ca2+ concentration and the 
quantal unit of Ca2+ influx, respectively. The activity of 
sparklets was determined by calculating the nPs of each 
sparklet site, where n is the quantal level number, and Ps 
is the probability that a sparklet site is active.
TRPV4 currents were measured before (control) and 
after the acute application of the hormone AngII (100 
nM), TRPV4 channel agonist (GSK1016790A; 100 nM), 
and antagonist (HC067047; 1 µM). TRPV4 currents and 
sparklets were recorded from freshly dissociated cells. 
Control records were obtained at least 5 min after suc-
cessful conversion to the whole-cell configuration of the 
patch-clamp technique. This ensured full equilibration 
between the contents in the pipette solution and the 
cytosol. Sparklet and current experiments were termi-
nated when the effects of a drug reached steady state. 
Although in multiple experiments currents and spar-
klets were recorded over a period of 10–15 min, in some 
experiments total recording time was extended up to 30 
min to verify the stability of the cellular response.
Our perfusion chambers have a low volume (200 µl), 
ensuring fast solution exchange (<30  s) at our flow 
rates. Cells were not incubated with any drugs, or hor-
mone, before being placed in our electrophysiology/
imaging recording chamber.
Super-resolution microscopy
Myocytes were plated on collagen-coated coverslips 
(Neuvitro) for 1 h at 4°C and fixed with 4% paraformal-
dehyde and 0.1% glutaraldehyde in PBS, for 10 min at 
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room temperature. After washing with PBS, cells were 
incubated with 0.1% NaBH4 for 5 min at room tempera-
ture (aldehyde reduction) and blocked with 20% SEA 
BLO CK (Thermo Fisher Scientific) and 0.25% Triton 
X-100 in PBS for 1 h at room temperature. Permeabi-
lized cells were incubated first with rabbit anti-TRPV4 
(10 µg/ml; SC-98592; Santa Cruz Biotechnology, Inc.) 
and goat anti-AKAP150 (10 µg/ml; SC-6446; Santa Cruz 
Biotechnology, Inc.) primary antibodies (overnight at 
4°C), and then with Alexa Fluor 647–conjugated don-
key anti-goat (1 µg/ml; Molecular Probes) and Alexa 
532–conjugated donkey anti-rabbit (1 µg/ml; Molec-
ular Probes) secondary antibodies (1  h at room tem-
perature). Coverslips were mounted on microscope 
slides with a round cavity (NeoLab) using MEA-GLOX 
imaging buffer and then sealed with Twinsil (Picodent). 
The imaging buffer contained 10 mM MEA, 0.56 mg/
ml glucose oxidase, 34 µg/ml catalase, and 10% wt/
vol glucose in TN buffer (50 mM Tris-HCl, pH 8, and 
10  mM NaCl). tsA-201 cells were processed following 
the same protocol.
Super-resolution images of TRPV4 and AKAP150 in 
arterial myocytes and tsA-201 cells were acquired with 
a Leica Microsystems ground state depletion (GSD) 
system coupled to a Leica Microsystems DMI6000B in-
verted microscope. Images were obtained using a 160× 
HCX PL APO (NA = 1.47) oil-immersion lens and an 
Andor iXon3 897 EMC CD camera. The Leica Microsys-
tems GSD system is equipped with high-power lasers 
with measured intensities at the focal plane of 1.4 kW/
cm2 for 488 nm, 2.1 kW/cm2 for 532 nm, and 2.1 kW/
cm2 for 642 nm. For image analyses, we set an event 
threshold of 50 events/pixel to eliminate background, 
nonspecific signals. High-resolution localization im-
ages were reconstructed using the coordinates of cen-
troids of these fluorescent particles obtained from 
>25,000 images.
Super-resolution localization maps of TRPV4 and 
AKAP150 were determined using the coordinates of 
centroids obtained by fitting single-molecule fluores-
cence signals with a two-dimensional Gaussian func-
tion using LAS AF software (Leica Microsystems). The 
localization accuracy (i.e., full width half maximum 
[FWHM]) of the system is limited by the statistical noise 
of photon counting. Thus, assuming the point-spread 
functions are Gaussian, the precision of localization is 
proportional to DLR/√N, where DLR is the diffrac-
tion-limited resolution of a fluorophore, and N is the 
mean number of detected photons per switching event 
(Dempsey et al., 2011). Accordingly, we estimated a 
theoretical lateral localization accuracy of ∼13 nm for 
Alexa 647 and ∼16 nm for Alexa 532. Spatial resolution 
of the GSD microscope was measured using the DNA-
PAI NT nanoruler method (GAT TAquant; Schmied et 
al., 2014). In brief, we used a 40R nanoruler consisting 
of immobilized single-stranded DNA strands with three 
binding sites for complementary ATTO655-labeled sin-
gle-stranded DNA separated by 40 nm. Drifting was cor-
rected using fiducial markers included in the probe and 
the GAT TAnalysis software. A histogram of the distance 
between dye molecules was generated using the same 
software. Using this approach, we experimentally deter-
mined the mean distance separating a 40-nm nanoruler 
to be 42.9 nm with an FWHM amplitude of 23.8 ± 6.8 
nm (Fig. S1). This FWHM value is comparable to our 
calculated lateral localization accuracy.
We performed two important control experiments to 
test the specificity of our TRPV4 and AKAP150 antibod-
ies (Fig. S2). Super-resolution images were obtained 
from tsA-201cells expressing TRPV4 and that were ex-
posed to both primary and secondary antibodies or 
secondary antibody only (Fig. S2, A and B). We also im-
aged tsA-201cells not transfected with TRPV4 (Fig. S2 
C), but exposed to primary and secondary antibodies. 
We found that the number of photons captured by our 
camera from cells transfected with TRPV4 was signifi-
cantly higher (∼20-fold) than from cells not expressing 
TRPV4, regardless of whether they were exposed to pri-
mary and/or secondary antibodies (Fig. S2 D). We also 
tested our AKAP150 antibody in WT and AKAP150−/− 
myocytes (Fig. S2, E–G). As with the TRPV4 antibody, 
the number of photons was significantly higher (∼14.5-
fold) in WT myocytes exposed to primary and second-
ary antibodies than WT cells exposed only to secondary 
antibody or AKAP150−/− cells exposed to primary and 
secondary antibodies.
A nearest neighbor analysis was performed to mea-
sure the distance between AKAP150 and TRPV4 chan-
nels in the super-resolution localization images. We 
used a region-based identification analysis using Cell-
Profiler software (Jones et al., 2008) and a custom vi-
sual basic array. This analysis uses a modular three-step 
strategy to identify objects on the basis of a previously 
published algorithm (Wählby et al., 2004). After the ob-
ject identification step, the distance from the edge of 
adjacent AKAP150 and TRPV4 clusters was determined.
Western blot analysis
Intact mesenteric and pial arteries were collected as 
described in the Isolation of myocytes from pial and 
mesenteric arteries and parenchymal arterioles section 
above and pooled from multiple mice: two for mesen-
teric and four for pial. Parenchymal arterioles were not 
included in these experiments because of limited tissue 
availability, which made Western blot analysis of protein 
in these vessels unreliable. Arteries in Mg2+-PSS solution 
were centrifuged at 10,000 g for 10 min at 4°C and re-
suspended in 40 µl ice-cold RIPA buffer plus protease 
inhibitors (Complete Mini Protease Inhibitor Cocktail; 
Thermo Fisher Scientific). Tissue was homogenized by 
hand on ice in a Dounce homogenizer and mixed with 
lithium dodecyl sulfate loading buffer with 5% β-mer-
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captoethanol. Samples were incubated at 50°C for 30 
min, and the total contents were loaded onto a 4%–12% 
Bis-Tris polyacrylamide gel. Proteins were separated by 
electrophoresis at 110 V (1.5 h, room temperature) and 
then wet-transferred to a nitrocellulose membrane at 
40 V (overnight, 4°C). Membranes were then washed 
in Tris-buffered saline (TBS) with 0.05% Tween 20 
(TBS-T) and blocked in 3% BSA TBS (overnight, 4°C). 
Membranes were subsequently incubated with primary 
antibody: TRPV4 (1:1,000), AKAP150 (1:1,000), or β- 
actin (1:2,000; 47778 mouse monoclonal; Santa Cruz 
Biotechnology, Inc.) either overnight at 4°C (TRPV4 
and AKAP150) or for 1  h at room temperature (β- 
actin). Membranes were then rinsed and incubated with 
the appropriate HRP-conjugated secondary antibody 
for 1 h at room temperature. After a final wash, the blots 
were incubated in 2 ml ECL Western Blotting Detection 
Reagents (RPN2106; GE Healthcare) for 2 min and sub-
sequently exposed to autoradiography film (HyBlot CL; 
Denville). Densitometry for immunoreactive bands was 
performed with ImageJ software (National Institutes of 
Health), and expression was normalized to the β-actin 
signal for each lane.
To provide further evidence for the specificity of our 
AKAP150 antibody, we performed Western blots using 
WT and AKAP150−/− pial arteries. Densitometry analy-
sis of these Western blots showed robust expression of 
AKAP150 in WT pial arteries and undetectably low lev-
els in AKAP150−/− arteries (Fig. S2). We did see a non-
specific band with an apparent molecular weight of ∼40 
kD in the WT and AKAP150−/− Western blots. However, 
because AKAP150-associated fluorescence signals are at 
least an order of magnitude higher than background, 
the impact of this nonspecific signal on our super-reso-
lution analyses is minimal. Full scale Western blots for 
TRPV4 and AKAP150 were also performed using WT 
male and female pial and mesenteric preparations. 
These Western blots show that our approaches can de-
tect differential levels of TRPV4 and AKAP150 expres-
sion in these vessels (Fig. S4).
RNAi
The expression of the human homologous for 
AKAP150, AKAP79, was down-regulated in tsA-201 cells 
using Stealth RNAi siRNA against AKAP79 (HSS114139; 
Invitrogen). A low GC content RNAi scramble duplex 
with no homology to vertebrate transcripts was used as 
a negative control (12935200; Invitrogen). siRNA and 
RNAi negative control were dissolved at a concentration 
of 20 µM in diethylpyrocarbonate-treated water or the 
dilution/annealing buffer provided by the manufac-
turer, respectively. siRNA transfection was performed 
using Lipofectamine 2000 and Opti-MEM reduced 
serum medium according to the manufacturer’s in-
structions (Invitrogen). In brief, the day before trans-
fection, cells were plated in six-well plates in medium 
without antibiotics and used at 90% of confluence to 
minimize toxicity. For each well, 500 pmol siRNA (25 µl 
from the 20 µM stock) was diluted in 250 µl Opti-MEM 
(Invitrogen). In a second tube, 5 µl Lipofectamine 2000 
(Invitrogen) was mixed with 250 µl Opti-MEM and in-
cubated for 15 min. The dilutions were combined and 
incubated for another 15 min. Cells were incubated at 
37°C in a humidified CO2 incubator for 48 h. The effi-
ciency of the siRNA was determined by real-time PCR.
RNA extraction and real-time PCR
Total RNA from tsA-201 cells or mouse arteries was iso-
lated and purified by applying 1 ml of TRIzol reagent 
per sample according to the manufacturer’s instruc-
tions (Invitrogen). RNA was purified using the RNeasy 
Mini kit (QIA GEN). Genomic DNA was digested using 
RNAase-free DNAase (1023460; QIA GEN). For cDNA 
synthesis, 1 µg total RNA was reverse-transcribed using 
the qScriptcDNA supermix (84034; Quanta Biosciences, 
Inc.). For real-time PCR, a cDNA amount equivalent to 
15 ng initial RNA was loaded per well and amplified 
using PowerUP SYBR Green Mastermix (A25742; Ap-
plied Biosystems) under the following conditions: 2 
min at 50°C initial UDG activation, denaturation for 
2 min at 95°C, followed by 40 cycles consisting of 15 s 
at 95° and 60 s at 60°C. Table S1 summarizes the sets 
of primers designed for each gene. Fold change in the 
expression of mRNA for TRPV4 and AKAP150 was cal-
culated using the 2−ΔΔCT method taking the geometric 
mean of the human control genes 18S, GAP DH, and 
α-actinin as reference in tsA-201 cells and the geometric 
mean of the mouse genes 18S, hypoxanthine-guanine 
phosphoribosyl transferase (HPRT), and β-actin in the 
artery samples.
In silico modeling
We developed a multidimensional mathematical model 
of TRPV4, AKAP150, and PKCα distribution and activ-
ities using experimentally acquired data. The volume 
simulated for the statistics is 5 µm × 5 µm × 5 µm. The 
animations (Videos 1, 2, 3, 4, 5, and 6) show a 2-µm 
× 2-µm × 0.3-µm space. TRPV4 channels and AKAP150 
clusters are distributed randomly on the two-dimen-
sional membrane (x-y plane) located at z = 0 µm. The 
numbers of TRPV4 channels and AKAP150 clusters 
(i.e., density) were chosen based on experimental val-
ues (Table 1). The diffusion of PKCα was simulated with 
the random walk process. Every time step, PKCα moves 
√(2*dt*DPKC), where dt is the time step. Therefore, a 
set of equations to simulate the random walk is 
  
⎧
 ⎪⎨
⎪⎩
 x t+1 =  x t +  √ 
_
 2 dt   D PKC sin ( θ ) cos ( ϕ ) 
    y t+1 =  y t +  √
_
 2 dt   D PKC sin ( θ ) sin ( ϕ )  
 z t+1 =  z t +  √ 
_
 2 dt   D PKC cos ( θ ) 
 , 
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where θ and ϕ are random numbers between 0 and π, 
and 0 and 2π, respectively.
We chose dt = 0.01 ms, and the total simulation time 
is 1,000 ms. The number of active PKCα is equal to the 
number of AKAP150 clusters. The lifetime of PKCα 
(τPKC) was varied from 5–20 ms. We assume that if the 
distance between PKCα and TRPV4 is less than 10 nm, 
a sparklet occurs for 10 ms. The TRPV4 channel activity 
is computed by the product of the number of sparklet 
and sparklet duration (number of TRPV4 sparklets × 
TRPV4 sparklet duration). The program codes are 
written in C++ and simulated in a high-performance 
computing cluster (24 nodes, Intel Xeon E3-1270, 3.4 
GHz, 32 GB random-access memory). Results were visu-
alized using MAT LAB.
Chronic AngII infusion
Mice (8–16 wk old) anesthetized with isoflurane (1–
5%) were implanted with a micro-osmotic pumps (1002 
model; Alzet). The pumps delivered AngII at 1.1 mg/
kg/d (Sigma-Aldrich) for 7 d.
Statistics
Data with a normal distribution are presented as mean ± 
SEM. Two-sample comparisons of parametric data were 
performed using Student’s t test. Multigroup compar-
isons were performed using ANO VA. A p-value < 0.05 
was considered significant.
Online supplemental material
Fig. S1 shows super-resolution images and analysis of 
the 40-nm nanoruler. Fig. S2 shows negative control ex-
periments showing the specificity of the AKAP150 and 
TRPV4 antibodies. Fig. S3 shows that TRPV4 cluster size 
was similar between nonpermeabilized cells exposed to 
a TRPV4 antibody that binds to the extracellular side of 
the channel and permeabilized cells incubated with an 
antibody against the cytosolic side of the channel. Fig. 
S4 shows that AKAP150 and TRPV4 expression is differ-
entially expressed in parenchymal, pial, and mesenteric 
arteries. Fig. S5 shows histograms of the measured dis-
tances between AKAP150 and TRPV4. Table S1 shows 
the primers used for real-time PCR. Videos 1, 2, 3, 4, 5, 
and 6 show three-dimensional simulations of randomly 
walking PKC and TRPV4 channel activity in male and 
female pial, parenchymal, and mesenteric myocytes.
R e s u lt s
TRPV4 currents are larger in male than in female arterial 
and arteriolar myocytes
We recorded whole-cell TRPV4 current (ITRPV4), defined 
as the current blocked by the specific TRPV4 antagonist 
HC067047 (1 µM; Everaerts et al., 2010), in pial, paren-
chymal, and mesenteric myocytes isolated from male 
and female mice (Fig.  1). To minimize alterations in 
[Ca2+]i and potential dialysis of key intracellular compo-
nents, we measured currents using the amphotericin B–
perforated patch-clamp technique. ITRPV4 was recorded 
during a 1-s voltage ramp from −80 to +80 mV before 
and after the application of 100 nM AngII, a potent va-
soconstrictor that also stimulates TRPV4 channel activ-
ity in vascular smooth muscle (Mercado et al., 2014).
We found that ITRPV4 was larger in male than in female 
pial myocytes (Fig. 1, A and D). A similar finding was 
obtained in comparisons of ITRPV4 in male and female 
parenchymal myocytes (Fig. 1, B and D). Notably, ITRPV4 
was, on average, indistinguishable from noise in both 
male and female mesenteric myocytes (Fig. 1, C and D). 
Our data suggest that application of AngII increased 
ITRPV4 in pial and parenchymal myocytes but not in male 
or female mesenteric myocytes. Indeed, for both sexes, 
ITRPV4 was larger in pial than parenchymal and mesen-
teric myocytes whether AngII was present or not (i.e., 
control). These data suggest that TRPV4 currents in ar-
terial myocytes vary according to the sex of the animal 
and the specific vascular bed.
TRPV4 sparklet activity is higher in male than female 
arterial and arteriolar myocytes
We investigated whether differences in TRPV4 channel 
activity and/or amplitude account for the disparities in 
Table 1. summary of super-resolution data
Parameter Pial Parenchymal Mesenteric
Male Female Male Female Male Female
TRPV4 AKAP150 TRPV4 AKAP150 TRPV4 AKAP150 TRPV4 AKAP150 TRPV4 AKAP150 TRPV4 AKAP150
Cluster density 
(clusters/µm2)
9.8 ± 0.3 35.3 ± 0.7 4.3 ± 0.2 26.3 ± 1.0 9.4 ± 0.6 18.3 ± 0.6 11.7 ± 0.6 10.3 ± 0.4 4.4 ± 0.2 8.8 ± 0.2 6.4 ± 0.3 5.2 ± 0.2
Cluster area 
(nm2)
1,834 ± 117 1,860 ± 46 1,285 ± 69 2,802 ± 128 1,245 ± 44 2,014 ± 77 1,054 ± 48 1,219 ± 44 1,507 ± 37 1,180 ± 29 1,195 ± 42 1,295 ± 62
TRPV4–
AKAP150 
overlap (%)
11.5 ± 0.7 11.5 ± 0.7 6.4 ± 1.6 6.4 ± 1.6 4.6 ± 0.7 4.6 ± 0.7 1.2 ± 0.3 1.2 ± 0.3 1.1 ± 0.2 1.1 ± 0.2 0.4 ± 0.02 0.4 ± 0.02
TRPV4–
AKAP150 
distance (nm)
69 ± 4 69 ± 4 130 ± 3 130 ± 3 120 ± 7 120 ± 7 251 ± 6 251 ± 6 224 ± 7 224 ± 7 347 ± 9 347 ± 9
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ITRPV4 detected in male and female pial, parenchymal, 
and mesenteric myocytes. TRPV4 channel activity was 
determined by recording TRPV4 sparklets using TIRF 
microscopy, as described previously (Navedo et al., 2006; 
Nystoriak et al., 2013; Mercado et al., 2014; Zhao et al., 
2014; Fig. 2). An advantage of recording TRPV4 spark-
lets using TIRF microscopy is that it allows the activity of 
individual channels from a relatively large membrane 
area to be recorded, thus enabling the identification of 
discrete sarcolemmal signaling microdomains.
CaV1.2 channels can also produce sparklets in vascu-
lar smooth muscle (Navedo et al., 2005, 2007; Amberg 
et al., 2007), but TRPV4 sparklets can be distinguished 
from CaV1.2 sparklets on the basis of their different 
amplitudes, pharmacology, and voltage dependencies 
(Mercado et al., 2014). Accordingly, experiments were 
performed in the presence of thapsigargin (1 µM), to 
eliminate Ca2+ release from the SR, and the dihydropy-
ridine antagonist nifedipine (10 µM), to block CaV1.2 
channels. All experiments were performed in the pres-
ence of physiological 2 mM external Ca2+ in the bath 
solution. At this Ca2+ concentration, TRPV4 sparklets 
have an amplitude of ∼50 nM (Mercado et al., 2014), 
whereas the amplitude of CaV1.2 sparklets (<18 nM) 
falls below the detection limit of our system (Navedo 
et al., 2005; Amberg et al., 2007). Under these experi-
mental conditions, any CaV1.2 channels not blocked by 
nifedipine are unlikely to produce a detectable sparklet 
that could confound interpretation of our data.
Fig.  2 shows representative TIRF images of pial 
(Fig.  2  A), parenchymal (Fig.  2  B), and mesenteric 
(Fig. 2 C) myocytes from male and female mice before 
and after application of the TRPV4 channel agonist 
GSK1016790A (100 nM; referred to hereafter as GSK). 
Time courses of [Ca2+]i at multiple sites in the sarco-
lemma of these cells, highlighted by green circles, are 
shown to the right of each image.
Amplitude histograms were generated for all TRPV4 
sparklets recorded in each myocyte type from male 
(Fig. 3 A) and female (Fig. 3 B) mice, and these data 
were fit to a multi-Gaussian function using a quantal unit 
of Ca2+ influx of 50 nM (corresponding to an F/F0 = 1.41 
± 0.25). These analyses showed that the amplitudes of 
elementary TRPV4 sparklets were similar in cells from 
different arterial beds in both sexes. In contrast, whereas 
application of 100 nM GSK increased TRPV4 sparklet 
density and activity in both female and male cells, the 
GSK-induced increase in TRPV4 sparklet activity in male 
pial (0.11 ± 0.02) and parenchymal (0.48 ± 0.14) myo-
cytes was ∼1.3-fold (0.09 ± 0.04) and ∼13-fold (0.04 ± 
0.01) higher than that in corresponding female myo-
cytes (Fig. 3, C and D). Indeed, as part of this analysis, we 
grouped nPs data from female and male cells and found 
that, on average, TRPV4 sparklet activity in the presence 
of GSK was higher in male (0.3 ± 0.08) than in female 
(0.06 ± 0.02) pial and parenchymal myocytes. Consistent 
with the ITRPV4 data, TRPV4 sparklets were not detectable 
in mesenteric myocytes under any experimental condi-
tion in mice of either sex (Fig. 2 C). These data suggest 
that differences in ITRPV4 amplitude among male and fe-
male pial, parenchymal, and mesenteric myocytes are 
likely the result of differences in TRPV4 channel activity 
and not the amplitude of elementary sparklets.
AngII increases TRPV4 sparklet activity in pial and 
parenchymal but not in mesenteric myocytes
We investigated whether the effects of AngII (100 nM) 
on TRPV4 sparklets vary according to the vascular bed 
Figure 1. ItRPV4 is larger in male than 
in female arterial and arteriolar myo-
cytes. (A–C) Representative ITRPV4 ob-
tained in myocytes from pial arteries 
(A), parenchymal arterioles (B), and 
mesenteric arteries (C) using the per-
forated patch/whole-cell configuration 
of the patch-clamp technique. ITRPV4 
was defined as the HC067047-sensi-
tive current (1  µM; control). ITRPV4 was 
obtained by subtracting current traces 
evoked by voltage ramps in the pres-
ence of HC067047 from traces in con-
trol conditions or in the presence of 100 
nM AngII. (D) Bar plot showing mean ± 
SEM ITRPV4 amplitudes at 80 mV in the 
presence and absence of 100 nM AngII 
in male (n = 5–6 cells per condition, 
five animals) and female (n = 5 cells per 
condition, six animals) pial, parenchy-
mal, and mesenteric myocytes. *, P < 
0.05; **, P < 0.01.
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and sex of the animal, as was the case for ITRPV4 (Fig. 1). 
TRPV4 sparklets were recorded before and after the 
application of 100 nM AngII (Fig. 4). Interestingly, we 
found that AngII increased TRPV4 sparklet activity in 
myocytes from most, but not all, vascular beds (Fig. 4, 
A–D). AngII increased TRPV4 sparklet density and ac-
tivity in pial myocytes (Fig. 4, E and F). Indeed, AngII 
increased nPs by ∼6.6-fold (from 0.010 ± 0.002 to 0.066 
± 0.014) in pial myocytes from males and by ∼2.3-fold 
(from 0.009 ± 0.002 to 0.021 ± 0.007) in those from fe-
males (Fig. 4 E). In parenchymal and mesenteric myo-
cytes, the situation was quite different. Whereas AngII 
increased TRPV4 sparklet activity ∼5-fold (from 0.02 
± 0.02 to 0.09 ± 0.04) in parenchymal myocytes from 
males, it had no effect on TRPV4 sparklet activity in 
these myocytes from females. In stark contrast, AngII 
had no effect on TRPV4 sparklets in either male or fe-
male mesenteric myocytes (Fig. 4, E and F). Together 
with the ITRPV4 data, these findings indicate that AngII 
signaling differentially modulates TRPV4 channel activ-
ity throughout the vasculature of male and female mice.
Differential TRPV4 channel and AKAP150 distribution 
in male and female pial, parenchymal, and 
mesenteric myocytes
AKAP150 is a scaffold protein that targets signaling 
proteins to their substrates in the sarcolemma of many 
cells, including vascular smooth muscle cells. Indeed, 
we have shown that AKAP150 is required for AngII-in-
duced sparklet activity and TRPV4 regulation in pial 
myocytes (Navedo et al., 2008; Mercado et al., 2014; 
Nystoriak et al., 2014). Using GSD super-resolution 
nanoscopy to investigate the spatial organization of 
TRPV4 channels and AKAP150, we found that TRPV4 
Figure 2. GsK activates tRPV4 sparklets in pial and parenchymal myocytes, but not in mesenteric myocytes. (A–C) Set of TIRF 
images showing representative male (left) and female (right) pial (A), parenchymal (B), and mesenteric (C) myocytes before (control) 
and after application of the TRPV4 channel agonist GSK (100 nM). Traces to the right of each image show the time course of [Ca2+]i 
in regions highlighted by green circles.
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channels and AKAP150 form clusters along the surface 
membrane of pial (Fig. 5 A), parenchymal (Fig. 5 B), 
and mesenteric (Fig. 5 C) myocytes.
We determined the area, density, distance, and de-
gree of overlap between TRPV4 and AKAP150 clusters 
in male and female parenchymal, pial, and mesenteric 
myocytes. These data are summarized in Table 1. In pial 
myocytes, the area of AKAP150 clusters was larger in fe-
males than in males. This sex-specific difference in area 
was reversed for TRPV4 clusters, which were larger in 
male than female pial myocytes. The density of TRPV4 
clusters was also higher in male than female pial myo-
cytes. AKAP150 cluster density was similarly higher in 
male than in female pial myocytes. In control experi-
ments, we found that TRPV4 cluster size was similar in 
nonpermeabilized and permeabilized cells exposed to a 
TRPV4 antibody that binds to the extracellular side (Fig. 
S3). These findings rule out the possibility that TRPV4 
clustering is an artifact of cellular permeabilization.
We tested the hypothesis that the distribution of 
AKAP150 or TRPV4 clusters in the sarcolemma of male 
and female parenchymal, pial, and mesenteric myocytes 
was random. To do this, we performed a nearest neigh-
bor analysis of TRPV4 or AKAP150 clusters in all cells 
and compared the calculated mean nearest neighbor 
distance and the associated variance to the theoretical 
values for an object with a distribution that followed a 
Poisson distribution. This analysis indicated there was 
not a significant difference (P > 0.05) between the spa-
tial distribution of AKAP150 and TRPV4 clusters and 
the predicted Poisson distribution in male and female 
parenchymal, pial, mesenteric myocytes. This suggests 
that the spatial distribution of AKAP150 and TRPV4 
clusters in vascular smooth muscle is stochastic.
We also performed a nearest neighbor analysis to 
determine the distance between AKAP150 and TRPV4 
clusters. This analysis suggested that, on average, 
AKAP150 and TRPV4 clusters were closer together in 
male than in female pial myocytes (Fig. 5 D and Fig. S5). 
Moreover, 12 ± 1% of clusters completely overlapped in 
males, whereas only 6 ± 2% overlapped in females.
We also detected differences in the organization 
and distribution of AKAP150 and TRPV4 in paren-
chymal myocytes (Table  1). However, in this vascular 
bed, male AKAP150 cluster area and TRPV4 cluster 
area were larger than those in females. The density of 
AKAP150 clusters was also larger in parenchymal my-
ocytes from males than females, whereas the TRPV4 
cluster density in myocytes from this vascular bed was 
similar in males and females. As was the case for pial 
myocytes, AKAP150 and TRPV4 clusters were further 
apart in female than in male parenchymal myocytes 
(Fig. 5 D and Fig. S5). Indeed, 5 ± 1% of TRPV4 and 
AKAP150 clusters overlapped in parenchymal myo-
cytes from males, whereas only 1 ± 0.3% overlapped in 
those from females.
In mesenteric myocytes, the area of AKAP150 clusters 
was comparable in males and females (P > 0.05; Table 1), 
but the area of TRPV4 clusters was larger in male than in 
female myocytes. Similar to results obtained in pial and 
parenchymal myocytes, AKAP150 and TRPV4 clusters 
were further apart in female than in male mesenteric 
myocytes (P > 0.05; Fig. 5 D and Fig. S5). Whereas 1.0 
± 0.2% of AKAP150 and TRPV4 clusters overlapped in 
Figure 3. sex- and vessel-specific 
variations in GsK-induced tRPV4 
sparklet activity in smooth muscle 
myocytes. (A and B) Amplitude histo-
grams of amalgamated TRPV4 sparklets 
in male (A) and female (B) myocytes 
(i.e., pial, parenchymal, and mesenteric 
myocytes) before (white bars) and after 
100 nM GSK (gray bars). Black (control) 
and red (GSK) lines show the best fits 
of the male and female data using a 
multi-Gaussian function with a quantal 
unit of Ca2+ influx of 50 nM. (C and D) 
Bar plots of mean TRPV4 sparklet ac-
tivity ± SEM (C) and density ± SEM (D) 
in male (n = 7–8 cells per condition, 12 
animals) and female (n = 8–9 cells per 
condition, 16 animals) pial, parenchy-
mal, and mesenteric myocytes. *, P < 
0.05; **, P < 0.01; ***, P < 0.001.
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Figure 4. AngII effects on tRPV4 sparklet activity in smooth muscle depend on sex and vascular bed. (A–C) TIRF images 
of representative male (left) and female (right) pial (A), parenchymal (B), and mesenteric (C) myocytes in the absence (control) 
and presence of 100 nM AngII. Traces to the right of each image show the time course of [Ca2+]i in regions highlighted by 
green circles. (D) Amplitude histograms of amalgamated TRPV4 sparklets in male (left) and female (right) myocytes (i.e., pial, 
parenchymal, and mesenteric myocytes) before (white bars) and after 100 nM AngII (gray bars). Black (control) and red (AngII) 
lines show the best fits of the male and female data with a multi-Gaussian function with a quantal unit of Ca2+ influx of 50 nM. 
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male mesenteric myocytes, only 0.4 ± 0.2% overlapped 
in these myocytes from females (P > 0.05).
Collectively, these super-resolution data suggest that 
the size and separation of AKAP150 and TRPV4 clus-
ters in smooth muscle myocytes differs according to sex 
and vascular bed. Notably, our data suggest a gradation 
in the separation between AKAP150 and TRPV4 clus-
ters in parenchymal, pial, and mesenteric myocytes. An 
analysis of the amalgamated data (Fig.  5  D) suggests 
that the distance between AKAP150 and TRPV4 clus-
ters in smooth muscle myocytes from different vessels 
followed the rank order, female mesenteric > female 
parenchymal > male mesenteric > female pial > male 
parenchymal > male pial.
Differential TRPV4 channel and AKAP150 protein 
expression in male and female pial, parenchymal,  
and mesenteric myocytes
TRPV4 and AKAP150 protein levels in parenchymal, 
pial and mesenteric arteries were analyzed using West-
ern blot analysis (Fig. S4). AKAP150 and TRPV4 pro-
tein was largest in male pial myocytes and lowest in male 
mesenteric myocytes. We generated plots of AKAP150 
or TRPV4 cluster density versus protein expression in 
the same vessel type. This analysis suggested that there 
is a linear relationship between TRPV4 and AKAP150 
expression and cluster density. Thus, AKAP150 or 
TRPV4 cluster density data are a valid indicator for pro-
tein expression in these cells.
(E and F) Bar plot of mean TRPV4 sparklet activity ± SEM (E) and density ± SEM (F) in male (n = 6–7 cells per condition, 11 
animals) and female (n = 8–9 cells per condition, 15 animals) pial, parenchymal, and mesenteric myocytes. *, P < 0.05; **, P < 
0.01; ***, P < 0.001.
Figure 5. differential tRPV4 channel 
and AKAP150 distribution in male and fe-
male mesenteric, pial, and parenchymal 
myocytes. (A–C) Super-resolution images 
of TRPV4 (green) and AKAP150 (red) in pial 
(A), parenchymal (B), and mesenteric (C) my-
ocytes. Smaller images to the right of each 
image show expanded views of the regions 
of interest (ROIs) marked by yellow squares as 
well as the binary version of the same ROIs 
(mask). Binary images were used to measure 
the cluster area and distance to nearest neigh-
bor. (D) Bar plot of the mean distance ± SEM 
between TRPV4 and AKAP150 clusters in 
male (n = 750 ROIs from five cells per vascular 
bed) and female (n = 750 ROIs from five cells 
per vascular bed). ***, P < 0.001.
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The activity of TRPV4 channels decays as their distance 
from AKAP150 increases
Having determined the distribution and location of 
AKAP150 and TRPV4 clusters with nanometer resolu-
tion, we examined the relationship between TRPV4 ac-
tivity and the intermolecular AKAP150–TRPV4 distance 
in male and female pial, parenchymal, and mesenteric 
myocytes. To accomplish this, we generated a plot of the 
mean TRPV4 sparklet (nPs) and channel (nPo) activity 
in each cell as a function of the mean distance separat-
ing AKAP150 and TRPV4 clusters in the same cell type 
(Fig. 6, A and B). We calculated nPo by dividing ITRPV4 
at −80 mV by the amplitude of the elementary TRPV4 
current recorded under similar experimental condi-
tions (approximately −3.7 pA at −80 mV; Mercado et 
al., 2014). This analysis provides two related, but in-
dependently obtained, measurements of TRPV4 chan-
nel activity in arterial myocytes. Accordingly, distance 
(Table 1), nPo (Fig. 1), and nPs (Figs. 3 and 4) values 
were obtained in separate experiments from male and 
female parenchymal, pial, and mesenteric myocytes.
Notably, TRPV4 channel activity decreased as the dis-
tance from AKAP150 to TRPV4 sparklet sites increased 
under basal conditions or in the presence of AngII. 
Data for basal and AngII-induced TRPV4 activity (i.e., 
nPs and nPo) could be fit with single-exponential func-
tions. The decay constants (τ) used to fit nPs and nPo 
values under control conditions and in the presence of 
AngII were 74 and 127 nm, respectively. Interestingly, 
this analysis indicated that basal and AngII-induced 
TRPV4 sparklet activity is undetectably low when the 
distance between AKAP150 and TRPV4 channels is 
>200 nm, regardless of the sex of the animal.
The distribution of AKAP150 is dynamic rather than 
static, particularly during AngII signaling (Mercado 
et al., 2014; Sonkusare et al., 2014). Indeed, we found 
that chronic AngII infusion altered this intermolecular 
distance in pial and parenchymal myocytes. In pial my-
ocytes, chronic AngII infusion increased the mean dis-
tance between AKAP150 and TRPV4 clusters from 69 ± 
5 to 183 ± 6 nm in males and from 131 ± 3 to 202 ± 4 nm 
in females (P < 0.05; Fig. 7 A). This was associated with 
a decrease in AKAP150 cluster density and transcript 
expression in male and female pial myocytes (Fig. 7, B 
and C). TRPV4 cluster density was also lower in AngII 
than in control male pial myocytes. Interestingly, AngII 
infusion increased TRPV4 cluster density and transcript 
levels in female pial arteries. PKCα expression was lower 
in AngII than in control male and female pial arteries. 
Together, these data are consistent with the view that 
chronic AngII infusion increases the distance between 
TRPV4 and AKAP150 clusters largely by decreasing ex-
pression of AKAP150 in male and female pial myocytes.
In parenchymal myocytes, however, chronic AngII 
treatment exerted opposite effects in males and females. 
In male parenchymal myocytes, chronic AngII infusion 
increased the mean distance between AKAP150 and 
TRPV4 clusters by nearly 100 nm (Fig. 7 A). In contrast, 
the distance between AKAP150 and TRPV4 decreased 
from 251 ± 6 to 226 ± 6 nm in female parenchymal 
myocytes. Notably, in pial and parenchymal myocytes 
from male and female infused with AngII, AKAP150–
TRPV4 distance values fall beyond the threshold for 
TRPV4 sparklet activation in Fig.  6. Accordingly, we 
found that acute application of 100 nM AngII failed to 
induce TRPV4 sparklet activity in male parenchymal 
myocytes isolated from mice chronically infused with 
AngII (Fig. 7, D–F).
The activity of TRPV4 channels is limited by the 
availability of PKCα
To test the hypothesis that TRPV4 channels in male and 
female mesenteric myocytes are silent because of the 
limited local availability of PKCα (Figs. 2 C and 4 C), 
we monitored [Ca2+]i and ITRPV4 in cells dialyzed with 
an intracellular solution containing activated PKCα (1 
U/ml; Fig. 8). In the representative female mesenteric 
myocyte shown, the vast majority (>95%) of the imaged 
sarcolemma exhibited sustained elevations in Ca2+ in-
flux after ∼5 min from the beginning the experiment 
(Fig. 8, A and B). Similar results were obtained in seven 
Figure 6. tRPV4 channel activity depends on its proxim-
ity to AKAP150 in arterial myocytes. (A and B) Mean TRPV4 
sparklet ± SEM (nPs; A) and channel ± SEM (nPo; B) activity were 
plotted against the mean nearest edge to edge distance cal-
culated from super-resolution maps using a nearest neighbor 
analysis. Solid lines show fits to the data using a single-expo-
nential function.
651JGP Vol. 149, No. 6
Figure 7. chronic infusion of AngII increases AKAP150–tRPV4 distance in pial and parenchymal myocytes. (A) Two-color su-
per-resolution localization maps of AKAP150 (red) and TRPV4 (green) in male (left) and female (right) pial and parenchymal myocytes 
from mice infused with AngII for 7 d. To the right, a zoomed-out image of the region of interest (top) and the binary image (mask, 
bottom) used for nearest neighbor analysis. The bar plot shows the mean ± SEM distance between AKAP150 and TRPV4 clusters in 
male (n = 1,000 ROIs from five cells per condition) and female (n = 1,000 ROIs from five cells per condition) pial and parenchymal my-
ocytes from control mice (i.e., saline infusion) and mice chronically infused with AngII. (B) Bar plot of the mean ± SEM cluster density 
for AKAP150 and TRPV4 in pial myocytes from male and female mice infused with saline solution (control) or with AngII. (C) Real-time 
PCR analysis of the mean ± SEM fold change of mRNA for AKAP150, TRPV4, and PKCα in control and AngII-infused arteries (n = 3). 
(D and E) TIRF images of male parenchymal myocytes in control conditions and during acute application of 100 nM AngII. The cell 
in D was isolated from a mouse infused with saline, whereas the cell in E was isolated from a mouse chronically infused with AngII. 
Traces at right show the time course of [Ca2+]i in regions highlighted by green circles. (F) The bar plot shows mean ± SEM TRPV4 nPs 
values in male parenchymal myocytes (n = 4 cells per treatment, eight animals) from control and AngII-infused mice before and after 
acute AngII treatment. *, P < 0.05; **, P < 0.01; ***, P < 0.001.
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independent experiments involving male and female 
mesenteric myocytes. In sharp contrast, the maximum 
fraction of the imaged membrane undergoing persistent 
Ca2+ influx in control cells was always small (1–5%).
In agreement with the data in Fig.  1, we could not 
detect ITRPV4 in control mesenteric myocytes (i.e., with-
out activated PKCα) before or after AngII application 
(Fig. 8 C). However, consistent with the [Ca2+]i data in 
Fig. 8, A and B, internal perfusion with activated PKCα 
induced an ITRPV4 that increased nearly threefold in 
response to AngII (Fig. 8 D). This increase in ITRPV4 is 
likely produced by an AngII-induced increase in PKCα 
activity in response to higher DAG and local Ca2+ levels 
in the cell. Collectively, these data suggest that although 
functional TRPV4 channels are broadly expressed in the 
surface membrane of mesenteric myocytes, the location 
and number of such sites that exhibit active Ca2+ influx 
are limited by the availability of PKCα. Taken together 
with data establishing a minimum effective distance 
between TRPV4 and PKC-associated AKAP150 clusters 
(Fig. 6), these findings further support the general con-
clusion that TRPV4 sparklet activity in smooth muscle 
myocytes is limited by the spatial distribution of PKCα.
An in silico analysis shows that TRPV4 channel activity 
depends on its proximity to AKAP150 clusters
We built a computational model to perform an in sil-
ico analysis of AKAP150 distribution, PKCα activity, and 
TRPV4 channel activity. The model incorporates the 
cluster area and densities generated using super-reso-
lution nanoscopy (Table  1). The model assumes ran-
dom distribution of AKAP150 and TRPV4 clusters in 
all cells. This assumption is reasonable, as analysis of 
super-resolution images from male and female pial, pa-
renchymal, and mesenteric myocytes revealed that the 
location of AKAP150 and TRPV4 clusters follows a Pois-
son distribution.
Fig.  9  A shows six two-dimensional images of simu-
lated TRPV4 (green) and AKAP150 (red) clusters. The 
areas and densities of these clusters are similar to those 
measured using super-resolution nanoscopy of pial, 
parenchymal, and mesenteric myocytes (Table 1). The 
distance between in silico clusters is similar to those 
measured in cells (Fig. 9 B). Using these data, we pro-
ceeded to generate three-dimensional model for TRPV4 
channel activity in male and female pial, parenchymal, 
and mesenteric myocytes. The model assumes that 
under basal conditions (i.e., low PKCα activity), there 
is one active PKCα per AKAP150 cluster in simulated 
male and female pial, parenchymal, and mesenteric my-
ocytes. The active PKCα detaches from AKAP150 and 
randomly walks near the sarcolemma. The model also 
assumes that a collision between a PKCα and a TRPV4 
channel will result in the opening of the channel.
The model uses the diffusion coefficient (D) and 
time constant of the activated state (τPKC) to simulate 
the range and duration of PKCα mobility. The diffu-
sion coefficient for activated Ca2+/DAG-sensitive PKCα 
in hippocampal neurons is 0.33 µm2/s (Craske et al., 
2005). Our sparklet and super-resolution data provide 
a means for estimating τPKC. For a two-dimensional dif-
fusional process, the mean distance that the signaling 
protein travels (r) = (2 × D × τPKC)1/2, where r is the 
distance at which 63% of PKCα will be inactive (Teruel 
Figure 8. Increasing PKcα availability evokes 
tRPV4 channel activity in mesenteric myocytes. 
(A) TIRF image of a representative male mesen-
teric myocyte dialyzed with active PKCα (1 U/ml) 
recorded 1–5 min after gaining access to the cell 
interior. (B) Spatially averaged [Ca2+]i from a myo-
cyte dialyzed with active PKCα in the presence of 
the L-type CaV1.2 channel antagonist nifedipine 
(10 µM). (C) TRPV4 current records obtained using 
the whole-cell patch-clamp configuration. TRPV4 
currents were defined as the fraction of the current 
sensitive to HC067047 (1  µM; control) and were 
obtained by subtracting current traces evoked by 
voltage ramps in the presence of HC067047 from 
traces in control conditions or in the presence of 100 
nM AngII. (D) Bar plot showing mean ± SEM fold 
increase in ITRPV4 at −80 mV in the presence (n = 7 
cells) and absence (n = 7 cells) of active PKCα in the 
pipette solution. *, P < 0.05.
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and Meyer, 2000). Our data suggest that r is ∼74 nm 
under basal conditions. Solving this equation for τPKC 
(assuming that PKCα has a similar diffusion coefficient 
in neurons and smooth muscle cells) yields a τPKC value 
of 8 ms under control conditions. The model uses these 
D and τPKC values. To provide a visual representation of 
how our model works, we created videos of simulations 
of PKCα diffusion and TRPV4 sparklets using these D 
and τPKC values as well as the areas and densities of these 
clusters of male and female pial, parenchymal, and mes-
enteric myocytes (Videos 1, 2, 3, 4, 5, and 6).
Fig.  9  C shows that in silico and in vitro (i.e., nPo) 
values of TRPV4 channel activity are similar. Thus, 
our model was able to reproduce the observation that 
TRPV4 channel activity is relatively high when the dis-
tance between TRPV4 and AKAP150 clusters is simi-
lar to that of male pial myocytes and lowest when it is 
similar to male and female myocytes. Importantly, our 
Figure 9. In silico analysis suggests that tRPV4 channel activity depends on its proximity to AKAP150. (A) Simulated images 
of randomly distributed TRPV4 (green) and AKAP150 (red) clusters in male and female pial (left), parenchymal (center), and mesen-
teric (right) myocytes. (B) Bar plot of the in vitro (measured using GSD super-resolution nanoscopy) and in silico distances between 
AKAP150 and TRPV4 clusters. (C) Experimentally determined (i.e., nPo) and in silico calculated TRPV4 channel activities. (D) Plot of 
in vitro (nPo; black squares and line) and in silico (red circle and line) TRPV4 channel versus the mean AKAP150 to TRPV4 distance. 
Solid lines show fits to the data using a single-exponential function.
Sex- and vessel-specific AKAP150–TRPV4 organization | Tajada et al.654
Figure 10. effects of the down-regulation of AKAP79 on tRPV4 activity. (A) Representative two-colored super-resolution images 
generated using GSD in control tsA-201 cells (left) and AKAP79-siRNA–treated cells (right) stained with anti-AKAP79 and anti-TRPV4 
antibodies followed by Alexa Fluor 568– and Alexa Fluor 647–labeled secondary antibodies, respectively. Composite and mask 
images to the right show the boxed regions at higher zoom. (B) Two histograms representing the frequency of distances between 
TRPV4 and AKAP70 proteins in control conditions (left, gray) and in AKAP79-siRNA–treated cells (right, red). Solid lines represent 
best-fit Gaussian distribution. TRPV4-AKAP distance means are 155.3 ± 5.25 nm in control cells and 352.1 ± 7.36 nm in AKAP-
siRNA cells. (C) Bar plot showing TRPV4, AKAP79, and overlap mean ± SEM areas (nm2) in control conditions and under presence 
of AKAP79-siRNA. (D) Real-time PCR analysis of mean ± SEM diffrence of AKAP79 mRNA in control, mock, and AKAP79-siRNA–
treated tsA-201 cells. (E) Representative TIRF images of TRPV4-EGFP in control (top) and AKAP79-siRNA–treated (bottom) tsA-201 
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model shows that, as in vitro, in silico TRPV4 channel 
activity decays exponentially as the distance between 
AKAP150 and TRPV4 clusters increases. The τin silico was 
69 nm, which is close to the experimentally determined 
τ for nPo and nPs (i.e., 74 nm; Fig. 9 D).
We simulated the effects of a 10-fold increase in the 
number of active PKCα per AKAP150 cluster in all myo-
cytes. The model predicted an increase in TRPV4 activ-
ity in all cell types. However, consistent with our in vitro 
data, TRPV4 sparklet activity was predicted to follow the 
same order as under control conditions. That is, TRPV4 
sparklet activity is highest in male pial myocytes and 
lowest in female mesenteric myocytes. Indeed, under 
basal (i.e., 1 active PKCα per AKAP150 cluster) and 
high PKCα activity (i.e., 10 active PKCα per AKAP150 
cluster) conditions, TRPV4 channel activity in female 
mesenteric myocytes was only 0.7% and 0.9% that of 
male pial myocytes, respectively.
In vitro and in silico down-regulation of AKAP79/150 
cluster density decreases TRPV4 channel activity
We tested the hypothesis that an increase in the dis-
tance between AKAP150 and TRPV4 cluster is suffi-
cient to decrease TRPV4 channel activity. To do this, we 
used tsA-201 cells transfected with EGFP-tagged TRPV4 
channels. These cells have endogenous AKAP79, the 
human orthologue of rodent AKAP150. We performed 
super-resolution imaging and recorded ITRPV4 in control 
cells and in tsA-201 cells treated with a siRNA against 
AKAP79 (Fig. 10). Treatment with this siRNA decreased 
AKAP79 expression by 80 ± 5%. The mean distance be-
tween AKAP79 and TRPV4 clusters increased from 155 
± 5 to 352 ± 7 nm in control and siRNA-treated cells. 
Consistent with our hypothesis, the magnitude of basal 
(i.e., unstimulated) TRPV4 currents (at +80 mV) were 
about threefold smaller in control (141 ± 18 pA) and 
siRNA-treated cells (45 ± 6 pA), even though TRPV4 
expression (assessed by measuring EGFP fluorescence) 
was similar in control and siRNA-treated cells. These 
findings suggest that AKAP79 targets PKCα to the sur-
face membrane of tsA-201 cells and that basal activ-
ity of the kinase is sufficient to elevate TRPV4 activity 
in these cells.
Finally, we used our mathematical model to per-
form an in silico test of the effects of 2-, 5-, and 10-
fold changes in AKAP150 or TRPV4 expression (i.e., 
cluster density) on TRPV4 channel activity in female 
and male mesenteric myocytes. Consistent with the 
tsA-201 experiments shown in Fig.  10, a decrease in 
AKAP150 cluster density was, by itself, sufficient to re-
duce TRPV4 sparklet activity in a simulated male and 
female mesenteric myocyte (Fig. 10 H). Furthermore, 
the model predicted that increasing TRPV4 expres-
sion is sufficient to induce higher PKCα-driven TRPV4 
channel activity in mesenteric myocytes (Fig.  10  I). 
Notably, increasing TRPV4 expression translated into 
larger in silico increases of TRPV4 sparklet activity in 
male than in female myocytes. For example, a fivefold 
increase in TRPV4 expression predicted a ≈2-fold in-
crease in sparklet activity in male but only a ≈1.1-fold 
increase in female myocytes.
d I s c u s s I o n
In this study, we provide a quantitative analysis of the 
relationship between the localization and activity of 
TRPV4 channels in male and female arterial and arteri-
olar myocytes. We found that basal and AngII-induced 
TRPV4 channel activity decays exponentially as the dis-
tance between TRPV4 and PKCα-associated AKAP150 
clusters increases in different vessels from male and fe-
male mice. A key finding is that TRPV4 sparklet activity 
falls to undetectable levels if the mean distance between 
these clusters is greater than 200 nm. An important 
implication of our findings is that by determining the 
distance between TRPV4 channels and AKAP150 using 
super-resolution nanoscopy, it is possible to make 
reasonable predictions of TRPV4 channel activity in 
smooth muscle, even without applying patch-clamp or 
imaging approaches.
Our in vitro and in silico findings add quantitative 
information to a structural model that has been pro-
posed to explain heterogeneous TRPV4 channel ac-
tivity along the surface membrane of endothelial cells 
and arterial and arteriolar myocytes (Fig.  11; Mer-
cado et al., 2014; Sonkusare et al., 2014). According 
to this model, the anchoring protein AKAP150 plays 
a central role in forming a macromolecular signaling 
complex that regulates TRPV4 channels, and hence 
TRPV4 sparklet activity, in vascular smooth muscle by 
targeting PKCα to specific regions of the sarcolemma. 
In arterial myocytes, PKCα is activated by an increase 
in local [Ca2+]i (e.g., CaV1.2 sparklet, TRPV4 sparklet, 
or ryanodine receptor-mediated Ca2+ spark) and DAG 
produced by the activation of Gq protein–coupled re-
ceptors, including AngII receptors. Biochemical and 
cell-based studies have suggested a potential mech-
anism for local Ca2+-dependent activation of PKCα 
(Hoshi et al., 2010), proposing that as Ca2+ enters the 
cell, it recruits Ca2+/calmodulin to a PKCα-containing 
cells. Bar plot of mean ± SEM TRPV4-EGFP fluorescence in control and AKAP79-siRNA–treated tsA-201 cells (right). A.U., arbitrary 
units. (F) Representative ITRPV4 records from a control and AKAP79-siRNA–treated cell. (G) Bar plot of the mean ± SEM amplitude 
of ITRPV4 at 80 mV in control and AKAP79-siRNA–treated cells. (H and I) Mathematical simulation of the effects of down-regulating 
AKAP150 (H) or up-regulating TRPV4 (I) on TRPV4 channel activity in male and female myocytes. **, P < 0.01; ***, P < 0.001.
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AKAP150 complex, which then releases PKCα, allowing 
it to initiate a random walk during which it can phos-
phorylate nearby targets.
Our data suggest that the overall level of TRPV4 
spark let activity is determined by the relative distance 
of AKAP150-associated PKCα from TRPV4 channel 
clusters as well as the number of active PKCα mole-
cules, their mobility, and, in principle, their lifetime. 
Although an increase in the number of active PKCα 
molecules could increase TRPV4 channel activity, total 
channel activity is limited by how far the channel is 
from where the kinase is anchored in the membrane. 
TRPV4 sparklet activity is at its highest when channels 
are ≤50 nm away from AKAP150 but becomes unde-
tectably low if clusters of these two proteins is located 
∼200 nm or more away from each other.
A question prompted by our work is, what determines 
the distance between AKAP150 and TRPV4 channels in 
male and female mesenteric, pial, and parenchymal my-
ocytes? Our data are consistent with the view that this is 
the result of the stochastic distribution of differentially 
expressed AKAP150 and TRPV4 proteins in the sarco-
lemma of parenchymal, pial, and mesenteric myocytes. 
The distance between TRPV4 and AKAP150 clusters is 
lowest in cells in which the expression of these protein 
is highest (i.e., male pial myocytes) and highest in cells 
in which their expression level is lowest (i.e., female 
mesenteric myocytes). Indeed, in mesenteric myocytes, 
which express functional TRPV4 channels, the expres-
sion of AKAP150/PKCα complexes seems to be a key 
limiting factor of TRPV4 activity. In these cells, increas-
ing AKAP150 expression is likely a more efficient strat-
egy to increase TRPV4 activity than increasing TRPV4 
expression alone. A future study should investigate 
the role of sex hormones, transcription factors, and 
microRNA, among other factors, in regulating the ex-
pression of AKAP150 and TRPV4 mRNA and protein in 
parenchymal, pial, and mesenteric myocytes.
A key feature of this model is that AKAP150 and 
TRPV4 channels are mobile and can interact dynam-
ically. Thus, the distance separating these proteins 
could change over time depending on physiological 
conditions. For example, an increase in the expression 
of TRPV4 and AKAP150 or the size and/or number of 
their respective clusters could potentially lead to a de-
crease in the distance between these two proteins. In 
any case, an interesting prediction of this model is that 
TRPV4 activity may not be restricted to a small, fixed 
number of channels. Instead, all TRPV4 channels in 
the membrane could potentially participate in Ca2+ in-
flux, but the specific subset of active TRPV4 channels 
could change with time depending on the proximity of 
AKAP150 complexes to these channels and the activity 
of AKAP150-associated PKCα.
Our study also sheds light on mechanisms of differ-
ential smooth muscle function along the arterial tree 
in both females and males. We detected clear differ-
ences in the activity of TRPV4 channels among vessels 
according to biological sex. Indeed, on average, the 
distance between TRPV4 channels and AKAP150, as 
well as TRPV4 sparklet activity, was higher in male than 
in female myocytes. Because TRPV4 channels oppose 
myogenic tone during AngII signaling, the expectation 
is that the role of TRPV4 channels in opposing vaso-
constriction will likely vary among vessels and between 
sexes. An analysis of our amalgamated data suggests 
that the ability of TRPV4 function to oppose AngII va-
soconstriction is lowest in female mesenteric myocytes 
and highest in male pial myocytes. Future experiments 
will be required to confirm this generalization.
Figure 11. A model depicting distance constraints on activa-
tion of tRPV4 channels by AKAP150-bound PKcα in vascular 
smooth muscle cells. Our in vitro and in silico data suggest 
that in arterial smooth muscle, the radius of action of an acti-
vated PKCα is ∼200 nm. In male and female pial myocytes as 
well as male parenchymal myocytes, the level of expression of 
AKAP150/PKCα complexes is sufficiently high to locate many 
of these complexes within 200 nm of TRPV4 channels. Accord-
ingly, TRPV4 activity in these cells is relatively high. In cells such 
as mesenteric myocytes, which express relatively low levels of 
AKAP150 and/or TRPV4, the density of these proteins in the 
sarcolemma is low. This results in an increase in the mean dis-
tance between AKAP150 and/or TRPV4 clusters. In cells (e.g., 
female parenchymal myocytes and male and female mesenteric 
myocytes) where the distance between these clusters is >200 
nm, TRPV4 channel activity is undetectably low.
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An intriguing finding of this study is that although 
mesenteric myocytes express functional TRPV4 chan-
nels, their activity is extremely low in these cells. 
Although our data show that TRPV4 channels are un-
responsive to the agonists GSK and AngII in mesenteric 
myocytes, it would be interesting to investigate whether 
they can be activated by 11,12-EET, as Earley and col-
leagues (Earley et al., 2005, 2009) previously demon-
strated occurs in pial myocytes. A difference in how 
TRPV4 channels in pial, parenchymal, and mesenteric 
myocytes respond to AngII and 11,12-EET could reflect 
different regulatory mechanisms of these channels as 
well as distinct physiological roles that could be neces-
sary to support responses to specific physiological de-
mands within each vascular bed.
Arterial smooth muscle depolarization and increased 
myogenic tone are hallmarks of hypertension. Our 
work provides insights into the mechanisms underlying 
smooth muscle dysfunction during this pathological 
condition. Chronic activation AngII signaling has been 
shown to elevate mean arterial pressure and decrease 
expression of the accessory β1 subunit of BK channels. 
Loss of β1 decreases the Ca2+ sensitivity and thus makes 
BK channels less likely to be activated by Ca2+ release via 
ryanodine receptors (i.e., Ca2+ sparks) in arterial myo-
cytes (Amberg et al., 2003; Nieves-Cintrón et al., 2007, 
2008). Here, we show that sustained elevations in AngII 
are associated with a decrease in TRPV4 function under 
basal conditions as well as in response to acute activation 
of AngII receptors. Our data suggest that this happens 
because sustained AngII signaling activation down-reg-
ulates AKAP150 and/or TRPV4, increasing the distance 
in the membrane between these two proteins. However, 
chronic activation of AngII receptors has also been 
shown to induce desensitization and internalization of 
these receptors (Sasamura et al., 1994; Oppermann et 
al., 1996; Ishizaka et al., 1997). Thus, a combination of 
lower TRPV4 activity (because of longer intermolecu-
lar distances between these channels and AKAP150/
PKCα complexes), AngII receptor desensitization, as 
well as lower β1 subunit expression are likely to lead 
to lower BK channel activity and thus to increased de-
polarization of arterial myocytes during hypertension. 
Membrane depolarization increases myogenic tone by 
increasing the opening probability of CaV1.2 channels, 
which elevates [Ca2+]i, and triggers contraction.
In conclusion, we propose that PKCα/AKAP150 and 
TRPV4 channels form dynamic signaling domains that 
control TRPV4 activity in arterial myocytes (Fig. 11). Ac-
tivation of Gq-coupled AngII receptors enhances TRPV4 
sparklet activity through activation of AKAP150-associ-
ated PKCα located near these channels. For optimal sig-
naling, AKAP150 and TRPV4 channel clusters must be 
located within ∼50 nm (or closer) of each other. If this 
distance exceeds 200 nm, TRPV4 channels are rendered 
incapable of responding to activation of AKAP150-as-
sociated PKCα. Because the relative distance between 
TRPV4 and AKAP150 is also an important determinant 
of TRPV4 sparklet activity in endothelial cells (Sonku-
sare et al., 2014), and perhaps other cells, our findings 
have broad implications in vascular and other cell types.
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